Showing 1481-1490 of 1775 results for "".
- BostonSight Scleral to Host Webinar on Using Fitkit Trial Lens Set for Successful Fittinghttps://modernod.com/news/bostonsight-scleral-to-host-webinar-on-using-fitkit-trial-lens-set-for-successful-fitting/2480885/BostonSight Scleral will host a one-hour scleral lens webinar on Tuesday, June 14, at 8 pm EDT with Suzanne Walter Sherman, OD, FAAO, and Steven Sorkin, OD, on how to get the most out of a BostonSight Scleral FitKit.
- American Academy of Optometry Foundation Announces Award Recipientshttps://modernod.com/news/american-academy-of-optometry-foundation-announces-award-recipients/2479474/Jonathan D. Lam, MD, OD, was this year’s recipient of the Hopkins Comprehensive Eye Care Award. Dr. Lam is a primary care/ocular disease resident at the Chinle Comprehensive Health Care Facility in Chinle, Arizona. Douglas W. Hopkins, OD, FAAO, was a leader within the Primary Care Section
- Neuro-Optometric Rehabilitation Association Announces Appointments of New Executive and Advisory Board Officershttps://modernod.com/news/neuro-optometric-rehabilitation-association-announces-appointments-of-new-executive-and-advisory-board-officers/2478297/The Neuro-Optometric Rehabilitation Association (NORA) announced the appointments of its new executive and advisory board members. DeAnn Fitzgerald, OD, assumes the position of President, succeeding Susan Daniel, OD, who now joins the NORA Advisory Board. Dr. Fitzgerald has been providing
- NASA Astronauts to Headline Heidelberg Engineering’s 2025 International Spectralis Symposiumhttps://modernod.com/news/nasa-astronauts-to-headline-heidelberg-engineerings-2025-international-spectralis-symposium/2482818/Heidelberg Engineering announced that NASA astronauts Warren Hoburg and Tyson Brunstetter, OD, PhD, will lead the keynote presentation at the company’s
- CooperVision Completes National Campaign on Childhood Myopiahttps://modernod.com/news/coopervision-completes-national-campaign-on-childhood-myopia/2487078/Key Takeaways CooperVision launched a nationwide media campaign focused on raising awareness about childhood myopia and promoting early diagnosis, intervention, and proactive treatment. The campaign was led by Damaris Raymondi, OD, and Coralys Vega, MD, who
- Three Optometric Practices in Florida Partner With US Eyehttps://modernod.com/news/us-eye-expands-into-now-5-states-50-clinics-and-5-ascs-100-providers-and-1000-team-members/2480526/Three optometric practices in Florida have partnered with US Eye. The new partnerships include Rick Billings, OD; Hart Eye Care; and Precision Eye Care of Central Florida.
- Oculus Names New Medical Directorhttps://modernod.com/news/oculus-names-new-medical-director/2478589/Oculus has announced that William Tullo, OD, FAAO, joined the company as a Medical Director on November 2nd, 2020. In this newly developed role, Dr. Tullo will provide clinical guidance and educate medical eye profess
- International Congress of Scleral Contacts: A Chance to Advance Your Skillshttps://modernod.com/news/international-congress-of-scleral-contacts-a-chance-to-advance-your-skills/2486922/Given that scleral contact lenses can manage corneal conditions, such as keratoconus, and treat dry eye disease effectively, it makes sense for ODs to be aware of the latest related innovations to continue to meet these patients’ vision and comfort needs. This is where the International Congress
- Aurion Makes Leadership Announcementshttps://modernod.com/news/aurion-makes-leadership-announcements/2482757/Aurion Biotech announced the appointments of Edward J. Holland, MD, as Chief Medical Officer, and Eris P. Jordan, OD, as Chief Development Officer. Aurion is developing AURN001, an investigational, single-administration, allogeneic cell therapy for the treatment of corneal edema seconda
- MediPrint Ophthalmics Unveils Phase 2b Trial Results for Drug-Eluting Contact Lens in Glaucoma Treatmenthttps://modernod.com/news/mediprint-ophthalmics-unveils-phase-2b-trial-results-for-drug-eluting-contact-lens-in-glaucoma-treatment/2482539/MediPrint Ophthalmics announced positive results from its phase 2b clinical trial of its 3D-printed, drug-eluting contact lens LL-BMT1. The results, presented by Ian Ben Gaddie, OD, FAAO, at the Ameri